KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardlytics (CDLX) Accumulated Expenses (2017 - 2025)

Cardlytics (CDLX) has disclosed Accumulated Expenses for 9 consecutive years, with $7.7 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Accumulated Expenses rose 40.61% year-over-year to $7.7 million, compared with a TTM value of $7.7 million through Dec 2025, up 40.61%, and an annual FY2025 reading of $7.7 million, up 40.61% over the prior year.
  • Accumulated Expenses was $7.7 million for Q4 2025 at Cardlytics, up from $7.5 million in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $21.0 million in Q2 2022 and bottomed at $4.3 million in Q1 2024.
  • Average Accumulated Expenses over 5 years is $10.0 million, with a median of $8.4 million recorded in 2024.
  • The sharpest move saw Accumulated Expenses skyrocketed 255.76% in 2021, then plummeted 58.93% in 2023.
  • Year by year, Accumulated Expenses stood at $19.6 million in 2021, then plummeted by 46.55% to $10.5 million in 2022, then increased by 11.21% to $11.7 million in 2023, then crashed by 52.89% to $5.5 million in 2024, then soared by 40.61% to $7.7 million in 2025.
  • Business Quant data shows Accumulated Expenses for CDLX at $7.7 million in Q4 2025, $7.5 million in Q3 2025, and $6.5 million in Q2 2025.